Sandler Laura Lee Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$370,795.08

Insider Activity of Sandler Laura Lee

According to the SEC Form 4 filings, Sandler Laura Lee, being in a position of

  1. Chief Operating Officer at Oruka Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 37431 share for $2.02M,
    over all time since 2026-01-02, has bought 0 shares, and sold 37431 share for $2.02M.

Biography of Sandler Laura Lee

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,019,8749100

Comparison of Insiders on Amount of Buys and Sells

2026-09-15SaleOruka Therapeutics, Inc.
ORKA
Chief Operating Officer
906
0.0016%
$95.71$86,713-8.69%
2026-09-01SaleOruka Therapeutics, Inc.
ORKA
Chief Operating Officer
5,000
0.0083%
$91.82$459,101-4.78%
2026-07-01SaleOruka Therapeutics, Inc.
ORKA
Chief Operating Officer
5,000
0.0132%
$94.42$472,079-1.44%
2026-06-15SaleOruka Therapeutics, Inc.
ORKA
Chief Operating Officer
600
0.0016%
$69.69$41,814+33.08%
2026-05-01SaleOruka Therapeutics, Inc.
ORKA
Chief Operating Officer
5,000
0.0125%
$63.88$319,384+37.52%
2026-03-16SaleOruka Therapeutics, Inc.
ORKA
Chief Operating Officer
600
0.0016%
$41.30$24,780+96.67%
2026-03-02SaleOruka Therapeutics, Inc.
ORKA
Chief Operating Officer
5,000
0.013%
$33.56$167,822+137.9%
2026-03-02SaleOruka Therapeutics, Inc.
ORKA
Chief Operating Officer
2,325
0.006%
$33.28$77,386+137.9%
2026-01-02SaleOruka Therapeutics, Inc.
ORKA
Chief Operating Officer
13,000
0.0363%
$28.52$370,795+143.85%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.